Medicines And Healthcare Products Regulatory Agency

Type: Organization
Name: Medicines And Healthcare Products Regulatory Agency
First reported May 16 2013 - Updated May 17 2013 - 1 reports

Dispensing errors tops Government board agenda

Decriminalisation of dispensing errors is top of the agenda for the Government board set up to review medicines legislation, it confirmed following its inaugural meeting.The 23-member rebalancing medicines legislation and pharmacy regulation programme ... [Published PJ Online - May 16 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

Clinical trials evidence session

The Science and Technology Committee will hold the following oral evidence session in its inquiry into ‘Clinical trials’ on Wednesday 15 May 2013.WitnessesCommittee Room 8, Palace of WestminsterAt 9.15 amProfessor Karol Sikora, Medical Director of Cancer ... [Published United Kingdom Parliament - May 15 2013]
First reported May 14 2013 - Updated May 14 2013 - 1 reports

Time running out for testing anti-counterfeit measures

Time is running out to develop and test a new UK system for tackling counterfeit medicines, pharmacy and industry leaders warned yesterday (13 May 3013) at an All-Party Pharmacy Group meeting in Westminster.There is an urgent need for the Government to ... [Published PJ Online - May 14 2013]
First reported May 14 2013 - Updated May 14 2013 - 1 reports

MHRA considers drug sales on planes and trains

UK watchdog the Medicines and Healthcare products Regulatory Agency (MHRA) has this month opened a public consultation on proposals to allow the sale of medicines on planes and trains.The Agency is looking into extending the scope of (GSL) medicines - ... [Published Pharma Times - May 14 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

Need to create platform among LDCs to boost pharma export

Bangladesh should take an effective initiative to create a platform among the 50 least developed countries (LDCs) of the Asia Pacific region and in Africa to help boost its pharmaceutical export to the less regulated markets, the industry people said ... [Published Financial Express Bangladesh - May 09 2013]
First reported May 08 2013 - Updated May 09 2013 - 2 reports

Plan for GSL medicines to be sold on trains and planes

General sale list (GSL) medicines could be sold on trains and aeroplanes if a proposal currently out for consultation is approved by ministers.The move would mean, for example, that passengers on long-haul flights would be able to purchase nicotine replacement ... [Published Pharmacy Magazine - May 09 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

MHRA warns of software fault in blood glucose meter

A warning has been issued about a software fault in a blood glucose meter that could give people with diabetes an incorrect low reading when their blood sugar levels are extremely high at 56.8mmol/L or more.Pharmacists should not dispense FreeStyle InsuLinx ... [Published PJ Online - May 08 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

Warning highlights risk of similar sounding drug names

Pharmacists are being warned to take particular care when prescribing or dispensing certain medicines whose similar names have recently led to medication errors.In its April 2013 Drug Safety Update , the Medicines and Healthcare products Regulatory Agency ... [Published PJ Online - May 08 2013]
First reported May 03 2013 - Updated May 03 2013 - 1 reports

DMHRA?s Five-Year Plan Puts Focus on Innovation-Spurring Schemes

The UK?s Medicines and Healthcare products Regulatory Agency (MHRA) plans to emphasize its ?earlier access? and ?adaptive licensing? programs to spur innovation, according to an agency five-year plan. Those initiatives, intended to speed the availability ... [Published FDA News - May 03 2013]
First reported May 01 2013 - Updated May 01 2013 - 1 reports

Diabetics warned to 'check meters'

Diabetes patients in the UK have been warned to check their blood glucose meters after officials discovered a potentially deadly flaw in some devices.The FreeStyle InsuLinx meter could give an incorrect low result when blood glucose levels are extremely ... [Published Breaking News.ie - May 01 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

EU list of “black triangle” medicines published

The European Medicines Agency has published its initial list of medicines subject to additional monitoring as part of the new EU-wide “black triangle” monitoring scheme . The scheme rolls out from 1 September 2013 and will replace the Medicines and Healthcare ... [Published PJ Online - Apr 29 2013]
First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

UK Safety Alert on Abbott MitraClip

The UK?s Medicines and Healthcare products Regulatory Agency issued a safety warning for Abbott Vascular?s MitraClip mitral valve repair device, stating the clip may not deploy successfully if the physician turns a knob on the clip delivery system in ... [Published FDA News - Apr 24 2013]

Quotes

Francesco Panella, spokesman for the European Beekeeping Coordination said, "The prohibition of systemic insecticides is a first step in the right direction to save bees and life in our fields. The decision is a great encouragement for good agricultural practices and for the preservation of Europe’s soil fertility. We must now ensure that the EU-Commission will act upon it to produce a coherent policy linking agriculture to nature and to life."
He told PJ Online: "I am pleased that the board is prioritising decriminalisation. What they [the DoH and MHRA] led us to believe at the time was [that] what was more important was the whole issue around remote supervision and how technicians could get involved in the process."
...Van Bokkelen. "We believe the cell therapy field has transformational potential, and we intend to help lead the way in making these new technologies a medical reality."
...Paul Ashton, President and CEO of pSivida Corp. "If the FDA approves ILUVIEN, we would be entitled to an additional $25 million milestone payment from Alimera as well as 20 percent of net profits, as defined, on any sales in the U S by Alimera. We are entitled to the same net profit share on sales of ILUVIEN for DME by Alimera in the EU, where Alimera has already launched in the UK and reported plans to launch in Germany in 2013."

More Content

All (111) | News (96) | Reports (1) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
Letters to the Editor Issue 206 [Published Positive Health - May 18 2013]
Synexus Celebrates International Clinical Trial... [Published Individual.com - May 17 2013]
Dispensing errors tops Government board agenda [Published PJ Online - May 16 2013]
Athersys (ATHX) Q1/13 Results – SELL until it s... [Published Proactive Investors USA - May 15 2013]
Clinical trials evidence session [Published United Kingdom Parliament - May 15 2013]
Athersys Reports First Quarter 2013 Results [Published TheStreet.com - May 14 2013]
Time running out for testing anti-counterfeit m... [Published PJ Online - May 14 2013]
pSivida: New ILUVIEN PDUFA Date October 17 [Pro... [Published Pharmacy Choice - May 14 2013]
MHRA considers drug sales on planes and trains [Published Pharma Times - May 14 2013]
Building Prefilled Syringe Capacity for the Future [Published Pharmaceutical & Medical Packaging News - May 11 2013]
Richard Parish, Chief Executive of RSPH and IHM... [Published Pharma-Mag - May 11 2013]
Need to create platform among LDCs to boost pha... [Published Financial Express Bangladesh - May 09 2013]
Plan for GSL medicines to be sold on trains and... [Published Pharmacy Magazine - May 09 2013]
Blue Guide [Published MHRA - May 08 2013]
Plan for GSL medicines to be sold on trains and... [Published PJ Online - May 08 2013]
Warning highlights risk of similar sounding dru... [Published PJ Online - May 08 2013]
MHRA warns of software fault in blood glucose m... [Published PJ Online - May 08 2013]
Getting the best garment service [Published Cleanroom Technology - May 07 2013]
Use of e-cigarettes continues to rise among Bri... [Published Action on Smoking and Health - May 07 2013]
pSivida: New ILUVIEN PDUFA Date October 17 [Published Individual.com - May 06 2013]
DMHRA?s Five-Year Plan Puts Focus on Innovation... [Published FDA News - May 03 2013]
Immunocore Limited Announces Appointment of to ... [Published BioSpace - May 02 2013]
Press release: MHRA issues warning about FreeSt... [Published MHRA - May 01 2013]
Diabetics warned to 'check meters' [Published Breaking News.ie - May 01 2013]
pSivida Corp. Announces New ILUVIEN(R) PDUFA Da... [Published Zecco - May 01 2013]
Minister announces new vaccination programme to... [Published Northern Ireland Executive - Apr 30 2013]
New vaccine against rotavirus for kids [Published UTV - Apr 30 2013]
Fake Viagra, Illegal Immigrants: A Bad Day Gets... [Published Balita Pinoy - Apr 29 2013]
EU list of “black triangle” medicines published [Published PJ Online - Apr 29 2013]
Cyberpills are bad for your health ; ONLINE MED... [Published Pharmacy Choice - Apr 25 2013]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Richard Parish, Chief Executive of RSPH and IHM... [Published Pharma-Mag - May 11 2013]
Professor Richard Parish is one of the four new non-executive members on the Public Health England’s (PHE) Advisory Board. PHE was established on 1 April 2013. It is an executive agency of the Department of Health which works with national and local ...
Meda Pharma allergic rhinitis drug Dymista gets... [Published PBR - News - Mar 14 2013]
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization to Meda Pharmaceuticals' nasal spray formulation Dymista for the symptomatic treatment of moderate to severe seasonal and perennial allergic rhinitis ...
Former Aptuit Employee Found Guilty Of Data Scam [Published Pharmalot - Mar 13 2013]
A former employee of the Aptuit clinical research organization was found guilty of altering pre-clinical trial data that was used to support applications to perform clinical trials, according to the UK’s Medicines and Healthcare products Regulatory ...
4 Healthcare Stock Stories for Weekend Investor... [Published Wall St. Cheat Sheet - Mar 08 2013]
Eli Lilly and Company ( NYSE:LLY ): Current price $30.70 Lilly and Kowa Pharmaceuticals America have announced the results of a study evaluating the efficacy of Livalo (pitavastatin) 4 mg compared with pravastatin 40 mg in lowering low-density lipoprotein ...
With a pill for every possible situation, pharm... [Published PharmaGossip - Feb 15 2013]
As if our suffering patients didn’t have it bad enough, now the pharmaceuticals go and announce the failure of yet more drug trials dashing hopes for the million UK sufferers of Alzheimer’s.“Your health is our top concern,” trumpets one pharmaceutical ...
1 2

Press Releases

sort by: Date | Relevance
Athersys Announces Authorization of Stem Cell C... [Published GlobeNewswire: Acquisitions News - Apr 17 2013]
Horizon Pharma Receives Marketing Authorization... [Published Marketwire - Breaking News Releases - Mar 07 2013]
Alnylam Files Clinical Trial Application to Ini... [Published Business Wire Health News - Jan 03 2013]
Alnylam Files Clinical Trial Application to Ini... [Published EON Health & Medicine - Jan 03 2013]
Horizon Pharma to Receive Approval of DUEXIS(R)... [Published Marketwire - Breaking News Releases - Dec 21 2012]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.